ClinicalTrials.gov
 Home    Search    Study Topics    Glossary  
 

  Full Text View  
  Tabular View  
  Contacts and Locations  
  Related Studies  
Phase II Study Evaluating Toxicity and Efficacy of Lenalidomide (Revlimid®) in Chemotherapy-Naïve Androgen Independent Prostate Cancer Patients

This study is currently recruiting participants.
Information provided by Oncology Specialists, S.C.
Please refer to this study by its ClinicalTrials.gov identifier: NCT00654186


Contacts
Contact: Kathy Tolzien, RN     847-410-0658     ktolzien@oncmed.net    
Contact: Phillip Gozun     847-410-0662     pgozun@oncmed.net    

Locations
United States, Illinois
Oncology Specialists, S.C     Recruiting
      Niles, Illinois, United States, 60714
      Contact: Kathy Tolzien, RN     847-410-0658     ktolzien@oncmed.net    

Sponsors and Collaborators
Oncology Specialists, S.C.
Celgene Corporation

Investigators
Principal Investigator:     Chadi Nabhan, MD     Oncology Specialists, SC    


U.S. National Library of Medicine,  Contact Help Desk
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act
U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services



Links to all studies - primarily for crawlers